For past Congresses, use the Browse menu.
HR 5382
116th Congress • 2019–2021 (Ended)

To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.


Organizations below reported lobbying activity on this bill. Expand to view filing details.
Loading filings…